JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$1.09B |
| 2 |
Broadcom
AVGO
|
+$1.03B |
| 3 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$970M |
| 4 |
Vanguard Short-Term Bond ETF
BSV
|
+$877M |
| 5 |
Verizon
VZ
|
+$875M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.58B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.37B |
| 3 |
TWX
Time Warner Inc
TWX
|
+$764M |
| 4 |
IBM
IBM
|
+$737M |
| 5 |
Philip Morris
PM
|
+$640M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.15% |
| 2 | Financials | 14% |
| 3 | Technology | 12.71% |
| 4 | Healthcare | 9.7% |
| 5 | Consumer Discretionary | 8.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1976
CALL
Rio Tinto
RIO
$151B
| $11.1M | ﹤0.01% |
200,000
+90,000
| +82% | +$5.04M |
2018 Q1
1 quarter
|
|
|
OPTU
1977
PUT
Optimum Communications Inc
OPTU
$359M
| $11.1M | ﹤0.01% |
650,000
+410,000
| +171% | +$7.57M |
2017 Q4
2 quarters
|
|
|
CLVS
1978
DELISTED
Clovis Oncology, Inc.
CLVS
| $11.1M | ﹤0.01% |
243,488
+25,407
| +12% | +$1.24M |
2013 Q2
20 quarters
|
|
1979
Funko
FNKO
$314M
| $11.1M | ﹤0.01% |
882,023
-28,799
| -3% | -$282K |
2017 Q4
2 quarters
|
|
|
GHL
1980
DELISTED
Greenhill & Co., Inc.
GHL
| $11.1M | ﹤0.01% |
389,162
+85,934
| +28% | +$2.1M |
2013 Q2
20 quarters
|
|
|
DF
1981
DELISTED
Dean Foods Company
DF
| $11M | ﹤0.01% |
1,051,076
-85,782
| -8% | -$810K |
2015 Q1
13 quarters
|
|
1982
PUT
Goldman Sachs
GS
$261B
| $11M | ﹤0.01% |
50,000
-11,400
| -19% | -$2.72M |
2016 Q4
6 quarters
|
|
1983
TransDigm Group
TDG
$60.7B
| $11M | ﹤0.01% |
31,947
+2,930
| +10% | +$963K |
2013 Q2
20 quarters
|
|
1984
Gildan
GIL
$7.76B
| $11M | ﹤0.01% |
391,416
-4,868,515
| -93% | -$141M |
2015 Q1
13 quarters
|
|
1985
PUT
GoPro
GPRO
$274M
| $11M | ﹤0.01% |
1,708,900
+1,408,900
| +470% | +$7.85M |
2018 Q1
1 quarter
|
|
1986
PUT
Deere & Co
DE
$180B
| $11M | ﹤0.01% |
78,700
+50,000
| +174% | +$7.37M |
2016 Q4
6 quarters
|
|
1987
Ironwood Pharmaceuticals
IRWD
$621M
| $11M | ﹤0.01% |
686,155
+569,153
| +486% | +$8.42M |
2014 Q3
15 quarters
|
|
1988
Plexus
PLXS
$7.2B
| $11M | ﹤0.01% |
184,488
+13,511
| +8% | +$806K |
2015 Q3
11 quarters
|
|
1989
LivaNova
LIVN
$4.12B
| $11M | ﹤0.01% |
109,993
+48,085
| +78% | +$4.37M |
2015 Q4
10 quarters
|
|
|
NEWR
1990
DELISTED
New Relic, Inc.
NEWR
| $11M | ﹤0.01% |
109,117
-5,566
| -5% | -$494K |
2016 Q4
6 quarters
|
|
1991
CALL
Sempra
SRE
$51B
| $11M | ﹤0.01% |
+189,000
| New | +$10.3M |
2018 Q2
0 quarters
|
|
1992
PUT
PVH
PVH
$3.5B
| $11M | ﹤0.01% |
+73,200
| New | +$11.5M |
2018 Q2
0 quarters
|
|
1993
Myriad Genetics
MYGN
$388M
| $11M | ﹤0.01% |
293,050
-92,670
| -24% | -$3.13M |
2013 Q2
20 quarters
|
|
|
1994
CALL
Goldman Sachs
GS
$261B
| $10.9M | ﹤0.01% |
49,600
+1,900
| +4% | +$453K |
2016 Q4
6 quarters
|
|
1995
ACI Worldwide
ACIW
$5.02B
| $10.9M | ﹤0.01% |
443,398
+136,707
| +45% | +$3.33M |
2013 Q2
20 quarters
|
|
|
ALXN
1996
CALL
DELISTED
Alexion Pharmaceuticals
ALXN
| $10.9M | ﹤0.01% |
88,000
-136,500
| -61% | -$16M |
2017 Q1
5 quarters
|
|
1997
Sprouts Farmers Market
SFM
$6.01B
| $10.9M | ﹤0.01% |
493,968
+182,946
| +59% | +$4.14M |
2014 Q2
16 quarters
|
|
1998
PUT
American Tower
AMT
$75B
| $10.9M | ﹤0.01% |
75,600
| – | – |
2017 Q1
5 quarters
|
|
|
GHY
1999
PGIM Global High Yield Fund
GHY
$450M
| $10.8M | ﹤0.01% |
794,165
-2,026
| -0.3% | -$28K |
2015 Q4
10 quarters
|
|
|
ALEX
2000
DELISTED
Alexander & Baldwin
ALEX
| $10.8M | ﹤0.01% |
460,968
+10,387
| +2% | +$231K |
2013 Q2
20 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2018 Portfolio in Review
As of Q2 2018, JP Morgan Chase held 5,918 positions worth $486B, up 4.2% from $467B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q2 2018 filing shows 539 new, 2,430 increased, 2,080 reduced and 346 closed positions. Its largest new stake was Evergy: 3,598,208 shares worth $202M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $2.58B.
By sector, the portfolio is most concentrated in Miscellaneous at 24% of assets, up from 23% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q2 2018 buy was Evergy: 3,598,208 shares worth $202M.
- JP Morgan Chase added most to Salesforce in Q2 2018, an estimated $1.09B increase.
- JP Morgan Chase's biggest Q2 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.58B.
- JP Morgan Chase fully exited Time Warner Inc in Q2 2018, selling an estimated $764M.
- JP Morgan Chase's ten largest holdings make up 17% of its $486B portfolio in Q2 2018.
- JP Morgan Chase opened 539 new positions and closed 346 in Q2 2018.
- JP Morgan Chase's portfolio value rose 4.2% quarter-over-quarter to $486B.
Based on JP Morgan Chase's 13F filing for Q2 2018, filed 14 Aug 2018.